Clinical Trials Logo

Clinical Trial Summary

The purpose of this pilot feasibility study is to evaluate the ability of the Perfusion Index to predict the return to spontaneous circulation of the out-of-hospital cardiac arrest patient during cardiopulmonary resuscitation. The performance of the perfusion index will also be compared to the current gold standard, end-tidal CO2 (EtCO2).


Clinical Trial Description

The aim of this observational research is to measure the predictive performance the perfusion index to predict a return of a spontaneous circulation (ROSC) during cardiopulmonary resuscitation (CPR). The research focuses on patients in out-of-hospital cardiac arrest (OHCA) and in-hospital cardiac arrest (IHCA) treated by the mobile intensive care unit of Saint Pierre University Hospital. The study will be a pilot observational study during cardiac arrest. During the study period a non-invasive sensor will be connected to the patient's finger to measure continously and non-invasively the perfusion index. This non-invasive measurement is done by means of an infrared light which has no known risks for the health of the patient and which is usually used for the measurement of arterial oxygen saturation (SatO2). No intervention is planned as no decision will be taken on treatment based on the collected values of perfusion index during the arrest and post-arrest care of the participants. The study will therefore be conducted during conventional advanced life support procedures without rescuers having access to the ongoing measurements. The study will end when the participant returns to spontaneous circulation (RACS) or when patients is admitted to the emergency ward, whichever comes first in a time frame of maximum two hours. The decision to stop resuscitation procedures will be made in accordance with the European Resuscitation Council (ERC) recommendations and the Resuscitation Termination Rules (TOR) for cardiac arrest. Pulsatility index values will be sampled at a 0.5 Hertz frequency. These values will be tested for their ability to predict ROSC within 2 minutes. Similarly, EtCO2 values (as a gold standard) will be analyzed from the time of first measure. The sensitivity and specificity of the collected values of EtCO2 in the prediction of ROSC will be compared, at the end of the study to the diagnostic sensibility and specificity of different thresholds of the perfusion index. The patient's consent will be requested at the moment when he/she recovers consciousness allowing the comprehension and signature of a consent after the cardiac arrest. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05383885
Study type Observational
Source Centre Hospitalier Universitaire Saint Pierre
Contact Stefano Malinverni, MD, Ph.D
Phone +32471268267
Email stefano.malinverni@stpierre-bru.be
Status Recruiting
Phase
Start date January 1, 2022
Completion date December 31, 2023

See also
  Status Clinical Trial Phase
Active, not recruiting NCT03700125 - Pre-hospital ECMO in Advanced Resuscitation in Patients With Refractory Cardiac Arrest. ( SUB30 ) N/A
Withdrawn NCT00593164 - Clinical Study of the LRS ThermoSuitâ„¢ System in Post Arrest Patients With Intravenous Infusion of Magnesium Sulfate Phase 2
Active, not recruiting NCT02244853 - Heart Rate and Cardiovascular Diseases Prognosis in People With Stable Coronary Artery Disease N/A
Active, not recruiting NCT00661128 - Genomics of Sudden Cardiac Arrest
Withdrawn NCT00573092 - Analyzing Gene Regions That May Interact With the Effectiveness of High Blood Pressure Drugs N/A
Completed NCT00376532 - Extracellular Matrix Marker of Arrhythmia Risk (EMMA) N/A
Completed NCT00241800 - Medications and the Risk of Sudden Cardiac Death N/A
Completed NCT00047411 - Home Use of Automatic External Defibrillators to Treat Sudden Cardiac Arrest Phase 3
Completed NCT00399503 - Assessment of Noninvasive Methods to Identify Patients at Risk of Serious Arrhythmias After a Heart Attack N/A
Completed NCT00004560 - Public Access Defibrillation (PAD) Community Trial Phase 3
Completed NCT00000531 - Antiarrhythmics Versus Implantable Defibrillators (AVID) Phase 3
Completed NCT00000480 - Multicenter Unsustained Tachycardia Trial (MUSTT) Phase 3
Completed NCT00005265 - Natural History of Coronary Heart Disease N/A
Completed NCT00000492 - Beta-Blocker Heart Attack Trial (BHAT) Phase 3
Completed NCT01949025 - Prevention of Serious Adverse Events in Acute Care Hospitals by Afferent Limb and Response Method Intervention - the ALARM Intervention Study. N/A
Completed NCT01789554 - The Use of Mobile Phones in Out of Hospital Cardiac Arrest to Increase Bystander CPR N/A
Completed NCT00382928 - Automatic External Defibrillation Monitoring in Cardiac Arrest Phase 1
Terminated NCT00189423 - ResQ Trial: Impact of an ITD and Active Compression Decompression CPR on Survival From Out-of-Hospital Cardiac Arrest N/A
Completed NCT04132466 - ASSURE WCD Clinical Evaluation - Conversion Efficacy Study N/A
Completed NCT00000609 - Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Phase 3